Correlation Between Editas Medicine and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Editas Medicine and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Editas Medicine and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Editas Medicine and DiaMedica Therapeutics, you can compare the effects of market volatilities on Editas Medicine and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Editas Medicine with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Editas Medicine and DiaMedica Therapeutics.
Diversification Opportunities for Editas Medicine and DiaMedica Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Editas and DiaMedica is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Editas Medicine and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Editas Medicine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Editas Medicine are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Editas Medicine i.e., Editas Medicine and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Editas Medicine and DiaMedica Therapeutics
Given the investment horizon of 90 days Editas Medicine is expected to under-perform the DiaMedica Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Editas Medicine is 1.12 times less risky than DiaMedica Therapeutics. The stock trades about -0.29 of its potential returns per unit of risk. The DiaMedica Therapeutics is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest 443.00 in DiaMedica Therapeutics on September 4, 2024 and sell it today you would earn a total of 91.00 from holding DiaMedica Therapeutics or generate 20.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Editas Medicine vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Editas Medicine |
| DiaMedica Therapeutics |
Editas Medicine and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Editas Medicine and DiaMedica Therapeutics
The main advantage of trading using opposite Editas Medicine and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Editas Medicine position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Editas Medicine vs. Beam Therapeutics | Editas Medicine vs. Crispr Therapeutics AG | Editas Medicine vs. Caribou Biosciences | Editas Medicine vs. Verve Therapeutics |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |